Shuttle Pharmaceuticals Holdings, Inc. — Form D

Shuttle Pharmaceuticals Holdings, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-15. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Adam ChambersRelated PersonGAITHERSBURG, MD
Christopher CooperRelated PersonGAITHERSBURG, MD
Yuying LiangRelated PersonGAITHERSBURG, MD
Angel LirianoRelated PersonGAITHERSBURG, MD
George ScorsisRelated PersonGAITHERSBURG, MD
Ryan TrasoliniRelated PersonGAITHERSBURG, MD
Christopher CooperDirectorGAITHERSBURG, MD
Christopher CooperExecutive OfficerGAITHERSBURG, MD
Tyvin RichExecutive OfficerGaithersburg, MD
Adam ChambersDirectorGAITHERSBURG, MD
Mira JungExecutive OfficerGaithersburg, MD
Angel LirianoDirectorGAITHERSBURG, MD
Sachin PathigodaDirectorGaithersburg, MD
George ScorsisDirectorGAITHERSBURG, MD
Timothy LorberExecutive OfficerGaithersburg, MD
Oleh NabytDirectorGaithersburg, MD
George ScorcisDirectorGaithersburg, MD
Steven RichardsDirectorGaithersburg, MD
Joseph TungDirectorGaithersburg, MD
Peter DritschiloDirectorGaithersburg, MD
Peter DritschiloExecutive OfficerGaithersburg, MD
Joshua SchaferDirectorGaithersburg, MD
Chris SenanayakeDirectorGaithersburg, MD
Michael Vander HoekExecutive OfficerGaithersburg, MD
Bette JacobsDirectorGaithersburg, MD

Other filings by this issuer (8)

FiledFormOfferingSold
2025-11-07D$2.5M$2.5M
2025-06-26D$4.3M$4.3M
2024-10-25D$1.3M$790K
2023-01-20D$4.0M$4.0M
2022-08-15D$500K$125K
2022-02-22D$2.0M$365K
2022-01-04D$500K$500K
2019-01-31D—$913K

More